Steven Yeh1, Gary Fahle, Christina J Flaxel, Peter J Francis. Show Affiliations » 1. Emory Eye Center, Emory University School of Medicine, Atlanta, Georgia, USA.
Abstract
Entities: Disease
Mesh： See more » Acyclovir/analogs & derivativesAcyclovir/therapeutic useAgedAged, 80 and overAntiviral Agents/therapeutic useDNA, Viral/analysisFemaleFluorescein AngiographyHerpes Simplex/complicationsHerpes Zoster Ophthalmicus/complicationsHerpes Zoster Ophthalmicus/diagnosisHerpes Zoster Ophthalmicus/drug therapyHerpesvirus 2, Human/geneticsHerpesvirus 2, Human/isolation & purificationHerpesvirus 3, Human/geneticsHerpesvirus 3, Human/isolation & purificationHumansMaleMiddle AgedPolymerase Chain ReactionRetinal Artery Occlusion/diagnosisRetinal Artery Occlusion/drug therapyRetinal Artery Occlusion/etiologyRetinal Necrosis Syndrome, Acute/complicationsRetinal Necrosis Syndrome, Acute/diagnosisRetinal Necrosis Syndrome, Acute/drug therapyRetinal Vein Occlusion/diagnosisRetinal Vein Occlusion/drug therapyRetinal Vein Occlusion/etiologyValacyclovirValine/analogs & derivativesValine/therapeutic useVisual Acuity/physiology
Substances： See more » Antiviral AgentsDNA, ViralValineValacyclovirAcyclovir
Year: 2012 PMID： 22491922 DOI： 10.1001/archophthalmol.2011.1735
Source DB: PubMed Journal: Arch Ophthalmol ISSN： 0003-9950